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With the rapid growth in the elderly segment of thepopulation, an increasing number of older patientswill have end-stage heart failure and require car-diac surgery.1 The demographic of patients under-
going left ventricular assist device (LVAD) implantation is ex-
pected to shift toward older and sicker patients in parallel. This
study was designed to determine the effect of advanced age on
postimplantation complications, bridge-to-transplantation rates,
and posttransplantation survival in LVAD recipients.
Patients and Methods
Two hundred one patients undergoing LVAD implantation at a
single center from July 1996 through April 2004 were retrospec-
tively reviewed. Patients were categorized according to 3 age
cohorts: group 1, less than 40 years; group 2, 40 to 59 years; and
group 3, 60 years or older. These groups were then compared with
regard to baseline characteristics, LVAD scores,2 postoperative
complications, bridge-to-transplantation rates, and posttransplan-
tation survival.
Data were represented as frequency distributions and percent-
ages. Values of continuous variables were expressed as means 
SD. Continuous variables were compared by the analysis of vari-
ance test, whereas nominal variables were compared using 2 tests.
Kaplan-Meier analysis was used to calculate long-term survival
along with log-rank P values when comparing groups.3 Significant
predictors of bridge to transplantation were identified by logistic
regression models. All data were analyzed with SPSS 11.5 soft-
ware (SPSS, Inc, Chicago, Ill).
Results
Demographics. Clinical characteristics of patients are shown
in Table 1. The number of patients in groups 1, 2, and 3 was 41
(20.4%), 104 (51.7%), and 56 (27.9%), respectively. There were
no significant differences in sex, mean body mass index, and mean
LVAD score among the 3 groups. Coronary artery disease as the
cause of heart failure was significantly more common in older
patients, whereas idiopathic cardiomyopathy and other causes
were significantly more common in younger cohorts. There was a
greater incidence of hypertension in older patients undergoing
LVAD implantation.
Postoperative complications and bridge-to-transplanta-
tion rates. LVAD pocket infections and any type of infection in
general were more frequent in group 2 compared with in groups 1
and 3. Postoperative stroke occurrence did not differ between
groups, whereas acute renal failure necessitating continuous veno-
venous hemodialysis was significantly more common in group 3
than in groups 1 or 2. Mean intensive care unit (ICU) length of stay
was significantly longer in group 3 compared with the younger
cohorts. Overall bridge-to-transplantation rates were comparable
among the 3 age groups (Table 1).
Posttransplantation survival. Posttransplantation actuarial
survivals at 1, 3, and 5 years were 93.6%, 86.4%, and 81.1% for
group 1; 90.1%, 86.7%, and 78.6% for group 2; and 84.1%, 76.9%,
and 69.6% for group 3 (P  .505, log-rank test; Figure 1).
Predictors of bridge to transplantation. Univariate analy-
sis revealed cause of heart failure (P  .015 for coronary artery
disease and P  .004 for idiopathic cardiomyopathy), LVAD score
(P  .001), and female sex (trend toward significance, P  .066)
as predictors of bridge to transplantation. Multivariate analysis
revealed only LVAD score as a significant independent predictor
of bridge to transplantation (hazard ratio, 0.730; 95% confidence
interval, 0.631-0.845; P  .001). Patients with low LVAD scores
demonstrated higher bridge-to-transplantation rates compared with
those with high LVAD scores. Age of 60 years or older was not a
significant predictor of bridge to transplantation in either univari-
ate or multivariate analyses.
Discussion
In our review older patients exhibited significantly higher rates of
heart failure caused by coronary artery disease, as well as a higher
preoperative incidence of hypertension. These findings are consis-
tent with previous reports.3 The mean intensive care unit stay was
significantly longer for elderly patients, an outcome likely related
to a corresponding increased incidence of postoperative renal
failure requiring continuous venovenous hemodialysis. Interest-
ingly, advanced age had no effect on either bridge to transplanta-
tion or posttransplantation survival. This might be expected, how-
ever, because several recent reports demonstrate comparable
posttransplantation survivals for older recipients as a result of
improvements in surgical technique, anesthesia management, and
perioperative care of patients.4
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Preimplantation LVAD score, which has previously been
shown to correlate with mortality, was the only independent pre-
dictor of outcome but was otherwise comparable among the dif-
ferent age cohorts.
Limitations of this study include those inherent with a retro-
spective analysis. Data were collected retrospectively by means of
chart review and might not be as accurate as data obtained in a
prospective and controlled fashion.
In conclusion, LVADs can successfully bridge older patients to
transplantation, with posttransplantation survivals equivalent to
those achieved by younger LVAD recipients. Decisions to implant
LVADs should not be based solely on age; rather, individualized
preoperative patient status should be more heavily considered in
the decision-making process.
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Figure 1. Posttransplantation actuarial survival.
TABLE 1. Demographics and clinical characteristics
Age <40 y Age 40-59 y Age >60 y P value
Age (y) 26.6  8.8 52.2  5.6 63.1  2.7 .001
Sex Female 24.4% 17.4% 14.3% .428
Race White 51.2% 71.2% 78.6% .011
Black 26.8% 14.3% 16.0% .197
Other 22.0% 13.5% 5.4% .054
Cause of HF CAD 17.1% 60.6% 76.8% .001
ICM 56.1% 33.6% 17.8% .001
Other 26.8% 5.8% 5.4% .001
LVAD score* 4.3  3.4 4.3  3.5 4.9  3.5 .611
Hypertension 10.0% 33.3% 37.3% .009
BMI (kg/m2) 27.5  6.5 27.1  5.2 26.5  4.8 .640
Infection Driveline 5.0% 6.1% 4.0% .858
Pocket 17.5% 17.3% 8.0% .279
Pump 2.5% 9.2% 0.0% .042
Any 35.0% 55.1% 37.3% .034
CVVHD 14.6% 35.3% 38.2% .028
Stroke 7.3% 4.8% 7.1% .771
ICU LOS (d) 13.1  14.9 14.5  11.6 22.6  28.7 .020
Bridge to transplantation 82.5% 73.5% 66.7% .228
HF, Heart failure; CAD, coronary artery disease; ICM, idiopathic cardiomyopathy; LVAD, left ventricular assist device; BMI, body mass index; CVVHD,
continuous venovenous hemodialysis; ICU, intensive care unit; LOS, length of stay. *Of 10 possible points.
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